Date: 28 October 2021
Time: 9am AEST
Location: Greenslopes Private Hospital
Contact Number: 07 3394 7284


NTM Australia Research Network
Inaugural Symposium

The inaugural symposium of the Nontuberculous Mycobacteria (NTM) Australia Research Network is a coming together of leading clinicians, researchers and scientists. Over the course of this event, attendees will have the opportunity to review clinical aspects of NTM diagnosis and management, hear about the latest research being conducted, and to discuss research priorities and opportunities for collaboration.

The objectives of the symposium are to:

  1.  Advance and share clinical knowledge in the field of NTM
  2. Disseminate the latest advances in translational research from around the world
  3. Provide a forum for researchers to present and discuss their work
  4. Facilitate collaborations across Australia to enhance the quality and outcomes of research in this field.

The two-day symposium will be held at Greenslopes Private Hospital and will be face-to-face including plenary sessions, abstract discussion and networking opportunities for all attendees.

Key outcomes

  • Establishing a more formal NTM Research Network in Australia with a focus on clinician education, community awareness, clinical trials and scientific research
  • Opportunities for future multi-disciplinary research between attendees
  • Increase the profile of NTM as an escalating public health problem.

NTM Forum Organising Committee

Professor Rachel Thomson

Respiratory Research Unit Head

Prof Rachel Thomson is a Thoracic Physician and clinical researcher working at Greenslopes Private Hospital and the Gallipoli Medical Research Foundation. Prof Thomson has an international  reputational for her research into lung disease due NTM. She is at the forefront of research and treatment of
patients with NTM infection.

Dr Andrew Burke

Dr Andrew Burke is a respiratory and infectious diseases physician based at The Prince Charles Hospital and current PhD student investigating ways to improve the administration of antibiotic therapies for patients with NTM
disease, by looking at how patients metabolise different drugs.




“10 years ago, all people had available was a prolonged course of three antibiotics. And if it didn’t work, you had no other options, and for a long time there was nothing new on the horizon. It’s fabulous to be able to offer new options for patients and provide a better understanding of their disease.”

Professor Rachel Thomson


Contact to register your interest and stay up to date with event details.